Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling
NCT ID: NCT00056186
Last Updated: 2008-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2003-03-31
2004-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients with Friedreich's ataxia who are 18 years of age or older may be eligible for this study. Those enrolled will participate in a 45- to 60-minute interview by phone or in person, in which they will be asked questions about important changes in their lives and their past experiences with health care providers. The interview will be audiotaped.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ataxia GAA-FGF14 - Descriptive Genetic and Clinical Study
NCT05884086
Genetics of Familial and Sporadic ALS
NCT00821132
Study of Clinical and Molecular Manifestations of Genetic Disorders
NCT00001466
Clinical Integration of Genetic Risk Assessment in Family Medicine
NCT00339794
Validation of a Clinical Algorithm for the Diagnosis of Recessive Ataxias
NCT04099914
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is anticipated that data elicited from the study will lead to recommendations regarding the process and content of genetic counseling for individuals with Friedreich's ataxia. These considerations, coupled with qualitative data obtained from participants, may also have implications for the evolving role of the genetic counselor. Specifically, consideration of developmental counseling approaches, which emphasize key transitional events, may be particularly useful as genetic counselors become increasingly involved in subspecialties (i.e. cardiology, pediatrics, neurology) that provide continuing follow-up care to patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Human Genome Research Institute (NHGRI)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Human Genome Research Institute (NHGRI)
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Beisecker AE, Cobb AK, Ziegler DK. Patients' perspectives of the role of care providers in amyotrophic lateral sclerosis. Arch Neurol. 1988 May;45(5):553-6. doi: 10.1001/archneur.1988.00520290089019.
Bernhardt BA, Biesecker BB, Mastromarino CL. Goals, benefits, and outcomes of genetic counseling: client and genetic counselor assessment. Am J Med Genet. 2000 Sep 18;94(3):189-97. doi: 10.1002/1096-8628(20000918)94:33.0.co;2-e.
Borreani C, Gangeri L. Genetic counselling: communication and psychosocial aspects. Tumori. 1996 Mar-Apr;82(2):147-50. doi: 10.1177/030089169608200209.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
03-HG-0118
Identifier Type: -
Identifier Source: secondary_id
030118
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.